EUVIMEDEUVIMED entdecken
Open Access

HSV-1 miRNAs are post-transcriptionally edited in latently infected human ganglia

Andreja Zubković, Cristina Gomes, Adwait Parchure, Mia Cesarec, Antun Ferenčić, Filip Rokić, Hrvoje Jakovac, Abigail L Whitford, Sara A Dochnal, Anna R Cliffe, Dražen Cuculić, Angela Gallo und 3 weitere

Journal of Virology · 2023

DOI: 10.1128/jvi.00730-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Andreja Zubković und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, University of Rijeka , Rijeka, Croatia. Hauptthemen laut MEDLINE: MicroRNAs, Herpesvirus 1, Human, Herpes Simplex. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viruses use miRNAs to enable efficient replication, control host defense mechanisms, and regulate latent infection. Herpes simplex virus 1 (HSV-1) expresses multiple miRNAs whose functions are largely unknown. The evolutionary conservation of many HSV-1 miRNAs in the closely related HSV-2 suggests their functional importance. miRNAs, similar to other transcripts, can undergo various post-transcriptional modifications that may affect their biogenesis, stability, and targeting. To investigate whether editing occurs in HSV-1 miRNAs, we sequenced samples from latently infected human ganglia. We show that one of the six HSV-1 miRNAs (miR-H2 to miR-H8) that define HSV-1 latency, miR-H2, exhibits adenosine-to-inosine hyperediting within the miRNA seed sequence. We observed the same specific miR-H2 hyperediting phenomenon in miRNAs isolated from the ganglia of latently infected mice and, to a lesser extent, during productive infection in cultured cells. Curiously, we found no evidence of editing of the encoded HSV-2 homolog in latently infected mice or in cultured cells. The efficient loading of the edited miRNAs onto the RNA-inducing silencing complex indicates their ability to function as miRNAs. To investigate the potential of the edited miRNA to alter mRNA targeting, we predicted the host and viral targets for the modified miRNAs. Nucleotide substitution in the seed region significantly increased the number of potential host and viral targets. Most notably, the mRNA that encodes ICP4, an essential viral protein, was predicted to be an additional target. Using transfection assays, we demonstrated that edited miRNAs have the potential to reduce ICP4 steady-state protein levels in addition to ICP0. Our study identifies a specific hyperedited HSV-1 mRNA, miR-H2, and highlights how the virus can use a single miRNA to target multiple transcripts during persistent, latent infection. IMPORTANCE Herpes simplex virus 1 is an important human pathogen that has been intensively studied for many decades. Nevertheless, the molecular mechanisms regulating its establishment, maintenance, and reactivation from latency are poorly understood. Here, we show that HSV-1-encoded miR-H2 is post-transcriptionally edited in latently infected human tissues. Hyperediting of viral miRNAs increases the targeting potential of these miRNAs and may play an important role in regulating latency. We show that the edited miR-H2 can target ICP4, an essential viral protein. Interestingly, we found no evidence of hyperediting of its homolog, miR-H2, which is expressed by the closely related virus HSV-2. The discovery of post-translational modifications of viral miRNA in the latency phase suggests that these processes may also be important for other non-coding viral RNA in the latency phase, including the intron LAT, which in turn may be crucial for understanding the biology of this virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsHerpesvirus 1, HumanHerpes SimplexHumansVirus LatencyViral ProteinsGangliaTrigeminal GanglionVirus Activation

Stichwörter der Autor:innen

ADARHSV-1RNA editinghuman trigeminal ganglialatencymiRNA

Substanzen

MicroRNAsViral Proteins

Autor:innen und Institutionen

  • Department of Biotechnology, University of Rijeka , Rijeka, Croatia.
  • Genetics Department and Biotechnology Institute, Biomedical Research Center (CIBM), University of Granada , Granada, Spain.
  • Faculty of Medicine, University of Rijeka , Rijeka, Croatia.
  • Laboratory for Advanced Genomics, Institute Ruđer Bošković , Zagreb, Croatia.
  • Department of Microbiology, Immunology and Cancer Biology, University of Virginia , Charlottesville, Virginia, USA.
  • Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS , Rome, Italy.

ORCID-Profile: Igor Jurak

Förderung

  • NINDS NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Hrvatska Zaklada za Znanost
  • University of Rijeka
  • HHS | National Institutes of Health
  • Fondazione AIRC per la ricerca sul cancro ETS

Zitieren

APA

Zubković, A., Gomes, C., Parchure, A., Cesarec, M., Ferenčić, A., Rokić, F., Jakovac, H., Whitford, A. L., Dochnal, S. A., Cliffe, A. R., Cuculić, D., Gallo, A., Vugrek, O., Hackenberg, M., & Jurak, I. (2023). HSV-1 miRNAs are post-transcriptionally edited in latently infected human ganglia. Journal of Virology. https://doi.org/10.1128/jvi.00730-23

Vancouver

Zubković A, Gomes C, Parchure A, Cesarec M, Ferenčić A, Rokić F, et al. HSV-1 miRNAs are post-transcriptionally edited in latently infected human ganglia. Journal of Virology. 2023. doi:10.1128/jvi.00730-23

BibTeX
@article{Zubkovi2023,
  author = {Zubković, Andreja and Gomes, Cristina and Parchure, Adwait and Cesarec, Mia and Ferenčić, Antun and Rokić, Filip and Jakovac, Hrvoje and Whitford, Abigail L and Dochnal, Sara A and Cliffe, Anna R and Cuculić, Dražen and Gallo, Angela and Vugrek, Oliver and Hackenberg, Michael and Jurak, Igor},
  title = {HSV-1 miRNAs are post-transcriptionally edited in latently infected human ganglia},
  journal = {Journal of Virology},
  year = {2023},
  doi = {10.1128/jvi.00730-23}
}
Kostenlos starten →